发明申请
- 专利标题： PIM-3 KINASE AS A TARGET FOR TYPE 2 DIABETES MELLITUS
- 专利标题（中）： PIM-3激酶作为2型糖尿病的目标
-
申请号： US11609652申请日： 2006-12-12
-
公开(公告)号： US20070154919A1公开(公告)日： 2007-07-05
- 发明人: Marc Korn , Guenter Mueller , Rudolf Schneider , Georg Tschank
- 申请人： Marc Korn , Guenter Mueller , Rudolf Schneider , Georg Tschank
- 申请人地址： DE Frankfurt 65929
- 专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人： Sanofi-Aventis Deutschland GmbH
- 当前专利权人地址： DE Frankfurt 65929
- 优先权： EP02001401.5 20020119
- 主分类号： C12Q1/68
- IPC分类号： C12Q1/68 ; C12Q1/48 ; C07H21/04 ; C12P21/06 ; C12N9/12
摘要：
The invention relates to isolated nucleic acid molecules and to host cells comprising such nucleic acid molecules. Moreover, the invention relates to a polypeptide having PIM-3 activity and having a definite amino acid sequence, as well as to the use of PIM-3 as a screening agent for identifying anti-type 2 diabetes mellitus drugs and for preparing a medicament for the treatment of insulin resistance or type 2 diabetes mellitus.
公开/授权文献
- US07629126B2 PIM-3 kinase as a target for type 2 diabetes mellitus 公开/授权日：2009-12-08
信息查询
